ArticleCancer biology & therapy2019

Dasatinib can enhance paclitaxel and gemcitabine inhibitory activity in human pancreatic cancer cells.

Ling Ma et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.